Pharmacist-CHW Team to Improve Medication Adherence and Reduce Hypertension Disparities
药剂师-CHW 团队致力于提高用药依从性并减少高血压差异
基本信息
- 批准号:10900852
- 负责人:
- 金额:$ 8.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-06 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherenceAfrican AmericanAutomobile DrivingBeliefBlood PressureBody mass indexCardiovascular DiseasesCardiovascular systemCaringCessation of lifeChronic DiseaseClinicalClinical PharmacistsCommunitiesCommunity Health AidesData CollectionDeath RateDiagnosisDisparityDistalDoseEducationEffectivenessElectronic Health RecordEthnic PopulationFaceFrightGlycosylated hemoglobin AHealthHealth InsuranceHealth Services AccessibilityHealth behaviorHealthcareHeart DiseasesHypertensionImmigrantIndividualInsurance CoverageIntentionInterventionKidney DiseasesLatinoLinguisticsLow Income PopulationLow incomeLow-Density LipoproteinsMeasuresMedication ManagementMedicineModelingNeighborhood Health CenterOutcomeParticipantPatient Self-ReportPatientsPharmaceutical PreparationsPharmacistsPlayPolypharmacyPopulation HeterogeneityPovertyPrimary CareQualifyingRandomizedRandomized, Controlled TrialsReduce health disparitiesRegimenReportingResearchResearch PersonnelResearch Project GrantsResourcesRisk FactorsRoleSelf ManagementServicesSiteSocial EnvironmentSocial supportStrokeSurveysTransportationVietnameseVulnerable PopulationsWaiting ListsWorkaccountable care organizationadherence rateadverse outcomeblood pressure controlcardiovascular risk factorcare coordinationcare providerscaucasian Americanclinical practicecomorbiditycostdesigndisparity reductioneffectiveness evaluationeffectiveness testingethnic disparityethnic minorityexperiencefood insecurityhealth literacyhigh riskhigh risk populationimprovedinnovationlow health literacymathematical abilitymedication compliancememberminority patientneglectpatient navigatorpatient orientedpillpost interventionprematurepreventprimary care providerprogramsracial disparityracial minorityracial minority populationracial populationresponseskillssocialsocial culturetheories
项目摘要
Abstract
The U.S. faces profound racial and ethnic disparities in hypertension, which are exacerbated by disparities in
medication adherence. Yet few existing medication adherence interventions are tailored to address the specific
cultural beliefs of diverse populations who also face significant structural barriers to adherence associated with
poverty, access to care and food insecurity. The proposed Improving Medication Adherence with Pharmacist
and CHW Team (IMPaCT) intervention responds to the call for adherence interventions that are tailored for the
specific needs of minority racial-ethnic groups. IMPaCT is a practice-based randomized controlled trial (RCT)
to test the effectiveness of a comprehensive, individually- and culturally-tailored intervention for high-risk
patients with hypertension, polypharmacy and low adherence. IMPaCT leverages the specialized expertise of a
clinical pharmacist together with a community health worker (CHW) who will serve as cultural broker and
patient navigator to address individual, clinical, social-cultural, and structural barriers to adherence. This
comprehensive and tailored, coordinated care intervention aims to improve medication adherence and
hypertension outcomes among African-American, Latino and Vietnamese immigrant patients. The proposed
practice-based RCT is designed to meet the following specific aims:
Aim 1: Implement IMPaCT, an innovative, tailored adherence intervention delivered by a pharmacist and
CHW team.
Aim 2: Determine the short- and long-term effectiveness of IMPaCT by assessing pre- to post-intervention
changes in: a) medication adherence (proximal outcome) and blood pressure (BP, distal outcome), and b)
other comorbid health outcomes (e.g., HbA1c, BMI) using a randomized controlled trial.
Aim 3: Identify factors associated with IMPaCT effectiveness including: a) tailored intervention features, b)
medication beliefs, c) barriers to adherence, d) intervention dose, e) health literacy, and f) cultural group.
We will follow an intention-to-treat randomized design using a waitlist control with 450 African-American,
Latino, and Vietnamese patients with hypertension and low (<80%) medication adherence. Data collection via
pill count, self-report, the electronic health record, and clinical measures will assess medication adherence, BP
and other factors at baseline (pre-intervention) and at 4, 10, and 24 weeks post-intervention. IMPaCT is an
innovative coordinated care team intervention to improve medication adherence and blood pressure derived
from research findings that builds on existing clinical practice. Designed with an eye towards sustainability,
IMPaCT incorporates billable pharmacist and CHW services for patients with low medication adherence and
high burdens of chronic illness and preventable consequences. IMPaCT offers interprofessional team care with
comprehensive expertise and complementary skill sets that mitigate the silo effect of specialized medicine to
deliver primary care to diverse, high-risk populations experiencing disparities in hypertension.
抽象的
美国面临着高血压的严重种族和种族差异,这会因差异而加剧
药物依从性。然而,很少对现有的药物依从性干预量来解决特定
不同人群的文化信仰,他们也面临着与之相关的重大结构性障碍
贫困,获得护理和粮食不安全。拟议的改善药剂师的药物依从性
和CHW团队(影响)干预措施应对针对依从性干预措施的呼吁做出回应
少数族裔种族群体的特定需求。影响是基于实践的随机对照试验(RCT)
测试对高风险的全面,单独和文化范围的干预措施的有效性
高血压,多药和依从性低的患者。影响利用了
临床药剂师与社区卫生工作者(CHW)一起担任文化经纪人和
患者导航员以遵守个人,临床,社会文化和结构性障碍来解决依从性。这
全面,量身定制的协调护理干预旨在改善药物依从性和
非裔美国人,拉丁裔和越南移民患者的高血压结局。提议
基于实践的RCT旨在满足以下特定目标:
目标1:实施影响,是药剂师和
CHW团队。
AIM 2:通过评估干预后确定影响的短期和长期有效性
更改:a)药物依从性(近端结局)和血压(BP,远端结果)和B)
使用随机对照试验的其他合并健康结果(例如HBA1C,BMI)。
目标3:确定与影响有效性相关的因素,包括:a)量身定制干预功能,b)
药物信念,c)遵守障碍,d)干预剂量,e)健康素养和f)文化群体。
我们将使用450名非裔美国人的候补控制列表控制遵循意向性的随机设计,
拉丁裔和越南患者患有高血压和低(<80%)的药物依从性。通过
药丸计数,自我报告,电子健康记录和临床措施将评估药物依从性,bp
以及基线(干预前)以及干预后4、10和24周时的其他因素。影响是一个
创新协调的护理团队干预措施,以提高药物依从性和血压
从基于现有临床实践的研究发现。设计着眼于可持续性
Impact为低药物依从性的患者提供了可计费的药剂师和CHW服务
慢性病和可预防的后果的高负担。 Impact提供跨专业团队的护理
综合专业知识和互补技能集可以减轻专业医学的孤岛效应
向高血压差异的多样化的高风险人群提供初级保健。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeannie Kim Lee其他文献
Jeannie Kim Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeannie Kim Lee', 18)}}的其他基金
Pharmacist-CHW Team to Improve Medication Adherence and Reduce Hypertension Disparities
药剂师-CHW 团队致力于提高用药依从性并减少高血压差异
- 批准号:
10295442 - 财政年份:2021
- 资助金额:
$ 8.1万 - 项目类别:
Pharmacist-CHW Team to Improve Medication Adherence and Reduce Hypertension Disparities
药剂师-CHW 团队致力于提高用药依从性并减少高血压差异
- 批准号:
10676327 - 财政年份:2021
- 资助金额:
$ 8.1万 - 项目类别:
Pharmacist-CHW Team to Improve Medication Adherence and Reduce Hypertension Disparities
药剂师-CHW 团队致力于提高用药依从性并减少高血压差异
- 批准号:
10628105 - 财政年份:2021
- 资助金额:
$ 8.1万 - 项目类别:
Pharmacist-CHW Team to Improve Medication Adherence and Reduce Hypertension Disparities
药剂师-CHW 团队致力于提高用药依从性并减少高血压差异
- 批准号:
10482342 - 财政年份:2021
- 资助金额:
$ 8.1万 - 项目类别:
Improving Hypertension Medication Adherence for Older Adults
提高老年人高血压药物的依从性
- 批准号:
10320448 - 财政年份:2020
- 资助金额:
$ 8.1万 - 项目类别:
Improving Hypertension Medication Adherence for Older Adults
提高老年人高血压药物的依从性
- 批准号:
9884987 - 财政年份:2020
- 资助金额:
$ 8.1万 - 项目类别:
Improving Hypertension Medication Adherence for Older Adults
提高老年人高血压药物的依从性
- 批准号:
10536620 - 财政年份:2020
- 资助金额:
$ 8.1万 - 项目类别:
Improving Hypertension Medication Adherence for Older Adults
提高老年人高血压药物的依从性
- 批准号:
10115134 - 财政年份:2020
- 资助金额:
$ 8.1万 - 项目类别:
相似国自然基金
坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
- 批准号:
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
- 批准号:72272131
- 批准年份:2022
- 资助金额:45.00 万元
- 项目类别:面上项目
不确定性下创业团队能量和抗逆力对创业坚持的权变影响研究
- 批准号:72162025
- 批准年份:2021
- 资助金额:29 万元
- 项目类别:地区科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
- 批准号:32100850
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Enhanced Medication Management to Control ADRD Risk Factors Among African Americans and Latinos
加强药物管理以控制非裔美国人和拉丁裔的 ADRD 风险因素
- 批准号:
10610975 - 财政年份:2023
- 资助金额:
$ 8.1万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 8.1万 - 项目类别:
Preventing Firearm Suicide Deaths Among Black/African American Adults
防止黑人/非裔美国成年人因枪支自杀死亡
- 批准号:
10811498 - 财政年份:2023
- 资助金额:
$ 8.1万 - 项目类别:
Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV.
建立美国国家队列以改善使用兴奋剂的艾滋病毒男性感染者的病毒抑制。
- 批准号:
10675863 - 财政年份:2023
- 资助金额:
$ 8.1万 - 项目类别:
Storytelling for Reducing Gap in AC Use in African Americans with Atrial Fibrillation
讲故事以减少患有心房颤动的非洲裔美国人使用交流电的差距
- 批准号:
10667019 - 财政年份:2023
- 资助金额:
$ 8.1万 - 项目类别: